PTEN and neoplasm: Clinical and molecular characteristics of the tumours, including METex14 mutations, MET expression score, MET gene amplification and other genetic alterations identified by CLAPv1 NSG, CGH and PTEN‐IHC [43, 47], are reported in Table S1.